Outsourcing

Pharmaceutical Outsourcing Present and Future

Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.

Navigating the Preclinical CRO Outsourcing Process

The need for preclinical testing expertise is growing as molecular complexity increases.

A Closer Look at Affinity Ligands

A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.

Texcell North America Builds New Laboratory Facility

January 28, 2022

Texcell North America’s new lab facility in Frederick, Md., will expand the CRO’s capabilities in R&D cell culture, viral clearance studies, and viral safety testing.

Samsung Biologics to Acquire Full Ownership of Samsung Bioepis in $2.3 Billion Deal

January 28, 2022

Samsung Biologics has signed an agreement with Biogen to acquire Biogen’s 50% stake in Samsung Bioepis, a joint venture formed by the two companies, for up to $2.3 billion.

Air France KLM Martinair Cargo and Envirotainer Collaborate on Sustainability

January 21, 2022

Air France KLM Martinair Cargo and Envirotainer are collaborating on more sustainable air transport of pharmaceuticals

Cyxone Engages European CDMO for Scale-Up and Production of T20K

January 21, 2022

Cyxone has appointed a European CDMO to scale-up and produce the active ingredient of its T20K drug candidate.

Protagen Protein Services, BioAnalytix, and GeneWerk Combine to Form New CRO, ProtaGene

January 18, 2022

After a previously announced merger, Protagen Protein Services, BioAnalytix, and GeneWerk have formed a new CRO under the name ProtaGene.

Drug Solutions Podcast: 2022 Bio/pharma Trends: US-Based Suppliers, Digitization, and Sustainability

January 18, 2022

In this episode of the Drug Solutions podcast, Chris Spivey, editorial director, and Meg Rivers, senior editor, interview experts on up-and-coming 2022 trends in the bio/pharma industry.

Fujifilm Grows Lab Space at North Carolina Facility

January 13, 2022

Fujifilm Diosynth Biotechnologies' 89,000 square-foot expansion of its BioProcess Innovation Center in Research Triangle Park, N.C., will double its capacity to support process characterization.

Merck KGaA Acquires CDMO Exelead

January 11, 2022

The agreeement will add to Merck KGaA’s LNP and mRNA capabilities.

Insightful Science Completes Acquisition of Protein Metrics

January 07, 2022

The acquisition of Protein Metrics expands Insightful Science’s R&D solutions to include proteomics.

Piramal Pharma Invests Minority Stake in India-Based CDMO, Yapan Bio

January 05, 2022

With this investment into Yapan Bio, Piramal Pharma adds new technologies and capabilities in large molecules, including vaccines and gene therapies, to its global offering.